Market Overview

Edwards Lifesciences Shares Fall As FDA Reports Recall Of Sapien 3 Ultra


The Food and Drug Administration reported Edwards Lifesciences (NYSE: EW) has recalled Sapien 3 Ultra delivery system due to burst balloons during surgery.

Reports first emerged in June that the company had issued a field safety notice regarding its Sapien 3 Ultra system for transcatheter aortic valve replacement (TAVR), warning physicians it has received reports of burst balloons.

This burst balloons may result in vascular injury, bleeding, or surgical intervention.

Edwards Lifesciences shares were trading down 3% to $215 at time of publication. The stock has a 52-week high of $226.41 and a 52-week low of $136.44.

Related Links:

The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Retrophin Flunks Late-Stage Study

Clearside Stock Plummets After Company Hints At Complete Response Letter For Macular Edema Drug


Related Articles (EW)

View Comments and Join the Discussion!

Posted-In: News FDA